Performance of EUCAST and CLSI approaches for co-amoxiclav susceptibility testing conditions for clinical categorization of a collection of Escherichia coli isolates with characterized resistance phenotypes

  1. Díez-Aguilar, M.
  2. Morosini, M.-I.
  3. López-Cerero, L.
  4. Pascual, Á.
  5. Calvo, J.
  6. Martínez-Martínez, L.
  7. Marco, F.
  8. Vila, J.
  9. Ortega, A.
  10. Oteo, J.
  11. Cantón, R.
Zeitschrift:
Journal of Antimicrobial Chemotherapy

ISSN: 1460-2091 0305-7453

Datum der Publikation: 2015

Ausgabe: 70

Nummer: 8

Seiten: 2306-2310

Art: Artikel

DOI: 10.1093/JAC/DKV088 GOOGLE SCHOLAR lock_openOpen Access editor